Kalaris Therapeutics Inc. (KLRS)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.3
Day's range
$10.19

Kalaris Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SAMSARA BIOCAPITAL, LLC 08/14/2026 12.88 M $52.43 M   -0.52% 54.13%
RTW INVESTMENTS, LP 08/14/2026 1.30 M $5.29 M   0.00% 5.46%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 572.69 K $2.33 M   0.00% 2.41%
SIREN, L.L.C. 08/13/2026 435.80 K $1.77 M   0.00% 1.83%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 398.71 K $1.62 M   56.14% 1.68%
IKARIAN CAPITAL, LLC 08/14/2026 360.00 K $1.47 M   0.00% 1.51%
UBS GROUP AG 08/13/2026 262.13 K $1.07 M   4,138.86% 1.10%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 149.35 K $607.86 K   125.77% 0.63%
MARSHALL WACE, LLP 08/13/2026 139.20 K $566.55 K   105.07% 0.59%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 114.04 K $464.29 K   30.26% 0.48%
WOODLINE PARTNERS LP 08/14/2026 100.00 K $407.00 K   0.00% 0.42%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 100.00 K $407.00 K   0.00% 0.42%
WHI TRUST CO LLC 08/11/2026 97.49 K $396.80 K   0.00% 0.41%
RAYMOND JAMES FINANCIAL INC 08/14/2026 97.16 K $395.46 K   -18.27% 0.41%
CITADEL ADVISORS LLC 09/02/2026 95.77 K $389.79 K   100.00% 0.40%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 92.26 K $375.50 K   0.00% 0.39%
VERDAD ADVISERS, LP 08/14/2026 80.30 K $326.81 K   100.00% 0.34%
MORGAN STANLEY 08/13/2026 72.33 K $294.37 K   88.62% 0.30%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 66.18 K $269.35 K   80.24% 0.28%
BLACKROCK, INC. 08/07/2026 54.44 K $221.58 K   51.05% 0.23%
BELPOINTE ASSET MANAGEMENT LLC 07/31/2026 40.00 K $162.80 K   0.00% 0.17%
FORTIS CAPITAL ADVISORS, LLC 07/31/2026 40.00 K $162.80 K   0.00% 0.17%
PALE FIRE CAPITAL SE 08/13/2026 39.63 K $161.28 K   100.00% 0.17%
SQUAREPOINT OPS LLC 08/14/2026 38.78 K $157.81 K   -2.51% 0.16%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 32.50 K $132.28 K   44.44% 0.14%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 30.12 K $122.60 K   47.66% 0.13%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 30.01 K $122.13 K   119.75% 0.13%
TREXQUANT INVESTMENT LP 08/14/2026 29.74 K $121.03 K   100.00% 0.13%
STATE STREET CORP 08/07/2026 26.51 K $107.90 K   0.00% 0.11%
NORTHERN TRUST CORP 08/13/2026 25.84 K $105.17 K   78.83% 0.11%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 25.00 K $101.75 K   38.89% 0.11%
TWO SIGMA INVESTMENTS, LP 08/14/2026 23.85 K $97.06 K   -22.20% 0.10%
WEALTHTRUST ASSET MANAGEMENT, LLC 07/27/2026 20.42 K $83.09 K   64.43% 0.09%
INDEPENDENT ADVISOR ALLIANCE 08/12/2026 18.13 K $73.77 K   27.37% 0.08%
RBF CAPITAL, LLC 08/14/2026 17.39 K $70.78 K   0.00% 0.07%
QUADRATURE CAPITAL LTD 08/07/2026 16.53 K $67.27 K   100.00% 0.07%
GOLDMAN SACHS GROUP INC 08/14/2026 16.05 K $65.34 K   -85.47% 0.07%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 15.96 K $64.99 K   100.00% 0.07%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 14.22 K $57.88 K   -73.01% 0.06%
HRT FINANCIAL LP 08/14/2026 13.72 K $55.00 K   18.13% 0.06%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 08/14/2026 12.50 K $50.88 K   212.50% 0.05%
VIRTU FINANCIAL LLC 08/13/2026 10.85 K $44.00 K   100.00% 0.05%
SIGMA PLANNING CORP 08/07/2026 10.17 K $41.38 K   100.00% 0.04%
FMR LLC 08/13/2026 7.81 K $31.77 K   0.00% 0.03%
INTEGRATED WEALTH CONCEPTS LLC 08/12/2026 5.00 K $20.35 K   100.00% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 2.56 K $10.42 K   1,741.73% 0.01%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 08/13/2026 2.22 K $9.02 K   0.00% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 08/13/2026 725 $2.95 K   0.00% 0.00%
BARCLAYS PLC 08/14/2026 303 $1.23 K   -94.26% 0.00%
STRENGTHENING FAMILIES & COMMUNITIES, LLC 08/11/2026 268 $1.09 K   0.00% 0.00%

Kalaris Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 69 institutional investors and hedge funds held shares of Kalaris Therapeutics Inc.. The most heavily invested institutionals were:

Samsara BioCapital, LLC: 12.88 M

RTW INVESTMENTS, LP: 1.3 M

Alyeska Investment Group, L.P.: 572,687

Siren, L.L.C.: 435,798

VANGUARD CAPITAL MANAGEMENT LLC: 398,712

Ikarian Capital, LLC: 360,000

75.79% of Kalaris Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 18.33 M shares in the last 24 months. This purchase volume represents approximately $183.29 M in transactions.